PODD Stock Price, Chart, Stats & News

Insulet Corporation
Save
10.10B
Market cap
34.06x
Current P/E
23.87x
Forward P/E
PODD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 71.63% |
Operating margin | 17.50% |
Pretax margin | 12.54% |
Net margin | 9.12% |
Effective tax rate | 27.19% |
ROA | 7.75% |
ROE | 17.36% |
D/E | 0.69x |
Interest coverage ratio | 7.40x |
PODD valuation
P/E | 34.06x |
P/S | 5.41x |
P/B | 9.67x |
P/CF | 25.74x |
P/FCF | 38.81x |
P/OCF | 25.74x |
PEG | 207.52x |
EV multiple | 29.44x |
About
Insulet Corporation specializes in the creation, production, and distribution of advanced insulin management systems for individuals living with insulin-dependent diabetes. At the core of their offerings is the Omnipod System, an innovative solution featuring a unique, self-adhesive, and disposable Omnipod device. This tubeless unit can be directly applied to the body for a duration of up to three days, and it operates in conjunction with a wireless handheld personal diabetes manager.
Similar securities
Based on sector and market capitalization
Report issue











